Patient Education Blog

Posts Tagged ‘anticoagulant’

FDA to review the drug Eliquis (apixaban) for DVT/PE treatment and prevention

| Blood thinners (anticoagulants), Eliquis - Apixaban, Prevention, Therapy | Comments Off on FDA to review the drug Eliquis (apixaban) for DVT/PE treatment and prevention

Stephan Moll, MD writes… Another ‘blood thinner’ medication is now under consideration by the FDA for the treatment of DVT and PE.

On Dec 19th the FDA accepted the application by Bristol-Myers Squibb (BMS) and Pfizer for review of Eliquis (apixaban) for the treatment of DVT and PE and for the reduction in the risk of recurrent DVT and PE.  The goal date for a decision by the FDA is August 25, 2014.  The press release about this submission from BMS is hereRead the rest of this entry »

Natural supplements, herbs, vitamins and food: do any prevent blood clots?

| Blood thinners (anticoagulants), Herbal remedies, Prevention, Therapy, Uncategorized | Comments Off on Natural supplements, herbs, vitamins and food: do any prevent blood clots?

Beth Waldron, Clot Connect Program Director and Stephan Moll, MD, Clot Connect Medical Director write….

Patients who have ended their recommended course of prescription anticoagulation treatment are understandably concerned about a clot recurrence and will ask “is there anything I can do to prevent a future clot?” Some have heard from friends or the internet that a particular herb, vitamin, or food will aid in the prevention of DVT and PE.

Since more than half of adults in the United States take a dietary supplement of some kind, it may be helpful to examine the science behind some of the most common natural supplements and foods said to prevent blood clots.[1] Read the rest of this entry »

Top clinically relevant publications for patients from 2012

| Blood thinners (anticoagulants), Prevention, Therapy | Comments Off on Top clinically relevant publications for patients from 2012

Beth Waldron and Stephan Moll, MD write….

While much is known about blood clots and clotting disorders, there is still much being learnt.  Medical information changes over time as new clinical trials, research studies and evidence-based guidelines contribute to knowledge of and treatments for blood clots and clotting disorders.  Many of today’s standards of treatment are based upon what was learned from publications in the past.

Over the past year, a number of publications emerged which will influence future clinical decisions and potentially impact your care. Here is a summary of the ‘top clinically relevant publications from 2012’ and how they may affect you. Read the rest of this entry »

Prescription assistance: when you can’t afford a medication

| Blood thinners (anticoagulants), Therapy | 6 Comments »

Beth Waldron, Program Director of the Clot Connect project, writes….

Approximately 1 in 5 people don’t take a medication a doctor has prescribed because they can’t afford to pay for it [ref 1].  While the cost of some outpatient “blood thinning” therapies (anticoagulants) can be substantial, failure to take a blood thinning medication as prescribed can have serious, even deadly, consequences.

What can you do when prescribed a blood thinner you cannot afford? Read the rest of this entry »

Savaysa (Edoxaban): New Oral Blood Thinner

| Blood thinners (anticoagulants) | 1 Comment »

Stephan Moll writes…

Savaysa® (Edoxaban), the 4th of the big new oral blood thinners in development (the other big 3 being Dabigatran = Pradaxa, Rivaroxaban = Xarelto, and Apixaban = Eliquis), is now commercially available in Japan (July 19th, 2011 press release here). It is available as once daily dosing for prevention of blood clots in the legs and lungs (DVT and PE) Read the rest of this entry »

DVT and PE: How Long to Treat with “Blood Thinners”

| Blood thinners (anticoagulants), Deep vein thrombosis (DVT), Length of treatment, Pulmonary embolism, Therapy | 32 Comments »

Stephan Moll, MD writes…

What Kind of Clot did You Have?

If you have had a blood clot in your legs or your lung (pulmonary embolism=PE), you will wonder how long you should stay on a “blood thinner”. The decision depends on a number of factors which will be discussed below. Read the rest of this entry »

EINSTEIN Xarelto Clinical Studies

| Blood thinners (anticoagulants), Deep vein thrombosis (DVT), Xarelto - Rivaroxaban | 1 Comment »

Summary

A major study published in December 2010 in the prestigious New England Journal of Medicine (NEJM) shows that the new oral “blood thinner” Xarelto® (=Rivaroxaban) is (a) as safe and effective as warfarin in patients with acute deep vein thrombosis (DVT), and (b) is quite effective in preventing recurrent blood clots (DVT and pulmonary embolism=PE) if taken longer-term, Read the rest of this entry »